Medifast, Inc. provided earnings guidance for the third quarter 2023. For the period, the company expects revenue to be in the range of $220 million to $240 million and third quarter 2023 diluted EPS to be in the range of $0.71 to $1.32.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.3 USD | -5.23% | -27.06% | -61.47% |
Apr. 30 | Medifast Shares Drop as Q1 Adjusted Earnings, Revenue Decline; Sets Q2 Guidance | MT |
Apr. 30 | Wall Street Poised for Cautious Day Ahead of Key Numbers, Earnings, Fed Report | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-61.47% | 285M | |
+13.21% | 8.15B | |
+3.59% | 7.52B | |
+12.30% | 6.65B | |
-7.02% | 3.73B | |
-6.99% | 3.72B | |
-4.78% | 1.31B | |
+12.61% | 972M | |
-36.30% | 958M | |
-15.78% | 876M |
- Stock Market
- Equities
- MED Stock
- News Medifast, Inc.
- Medifast, Inc. Provides Earnings Guidance for the Third Quarter 2023